Healthcare Education Services has announced details of two additional oncology specific courses to add to its comprehensive range of medical education for the pharmaceutical industry.
Healthcare Education Services has announced details of two additional oncology specific courses to add to its comprehensive range of medical education for the pharmaceutical industry. The new programmes from Healthcare - "Breast Cancer: Treatment and Management" and "Update on Cancer and its Treatment" - have been developed in response to delegate request and feedback and in-line with Healthcare's ongoing aim to address current information needs of those involved in the fast moving therapeutic area of oncology.
"Update to Cancer and its Treatment" will be launched in summer 2008. Taking place in London on 2nd and 3rd July, the programme is directed towards an audience with an existing knowledge and understanding of basic cancer terminology and classification. Ideally, delegates will have attended Healthcare's 'Introduction to Oncology and Chemotherapy' or 'Oncology Clinical Experience Programme' or may have worked in the area of oncology for a period of time. Course content will include major tumour types (breast, lung, upper gastrointestinal, colon, gynaecological) and include a review of recent advances in the detection and management of these cancers. Potential molecular targets will also be examined.
"Breast Cancer Day" is one of Healthcare's cancer target specific range of programmes. This one-day course, to be held in London on December 4th 2008, provides a general overview of breast cancer. It is ideal for individuals who are new to the therapy area or who have a particular interest or involvement in the subject. Equally, those with an existing basic knowledge of breast cancer will find this course enlightening and beneficial gaining further insight into the subject through detailed presentations by Healthcare's expert faculty.
Healthcare's training courses are designed to provide high-quality education in a range of therapy areas and a variety of marketing issues. They are lively and interactive, led by expert faculty and involve lectures, case discussions and group work, encouraging delegates to develop a thorough understanding of the topic concerned. The courses are ideal for both medical and non-medical staff within the pharmaceutical industry, including those from clinical research, medical information, regulatory affairs, biometrics and strategic marketing departments.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.